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Abstract
Objective: To assess the psychometric properties of the official Brazilian Portuguese-language version of the 
Paediatric Asthma Quality of Life Questionnaire (PAQLQ) in a representative group of Brazilian children and 
adolescents with asthma. Methods: A total of 125 individuals with asthma, aged 8-17 years and being monitored 
at a pediatric pulmonology outpatient clinic in the city of Porto Alegre, Brazil, completed the PAQLQ. Validity was 
assessed by means of convergent validity (correlation between PAQLQ domains and those of the Pediatric Quality 
of Life Inventory (PedsQL) 4.0. Reliability was assessed by determining internal consistency (Cronbach’s alpha 
coefficient), reproducibility (intraclass correlation coefficient), sensitivity to change (effect size), and discriminatory 
power (floor/ceiling effects). Results: The mean age was 11 years, and 75 (60%) of the participants were male. The 
mean PAQLQ total score was 5.1, with floor/ceiling effects < 10%. Correlations between PAQLQ domains and the 
PedsQL 4.0 domains were acceptable (r = 0.37-0.40). The Cronbach’s alpha coefficient for the total score was 0.93, 
ranging from 0.72 to 0.88 for the domains. The overall effect size was 0.60 (range: 0.45-0.60), whereas the overall 
intraclass correlation coefficient was 0.80 (range: 0.66-0.79). Conclusions: The official Brazilian Portuguese-
language version of the PAQLQ showed good psychometric performance, confirming its cultural adequacy for use 
in Brazil. 
Keywords: Quality of life; Asthma; Validation studies.
Resumo
Objetivo: Determinar as propriedades psicométricas da versão oficial em português do Brasil de Paediatric Asthma 
Quality of Life Questionnaire (PAQLQ) em uma amostra representativa de crianças e adolescentes brasileiros 
com asma. Métodos: Um total de 125 participantes com asma, com idades de 8-17 e monitorados em um 
ambulatório pediátrico de pneumologia em Porto Alegre (RS), responderam o PAQLQ. A validade foi avaliada 
através de validade convergente (correlação entre os domínios do PAQLQ e os domínios do Pediatric Quality of 
Life Inventory 4.0 (PedsQL 4.0). A confiabilidade foi avaliada através da consistência interna (coeficiente alfa de 
Cronbach), reprodutibilidade (coeficiente de correlação intraclasse), sensibilidade a mudança (tamanho do efeito) 
e discriminação (efeitos mínimo/máximo). Resultados: A idade média foi de 11 anos, e 75 (60%) eram meninos. 
A média do escore global do PAQLQ foi de 5.1, com efeitos mínimo/máximo < 10%. As correlações com os 
domínios do PedsQL 4.0 foram aceitáveis (r = 0,37-0,40). O coeficiente alfa de Cronbach do escore global foi 0,93, 
variando de 0,72 a 0,88 nos domínios. O tamanho do efeito global foi de 0,60 (variação: 0,45-0,60), e a correlação 
intraclasse global foi de 0,80 (variação: 0,66-0,79). Conclusões: A versão oficial em português do Brasil do PAQLQ 
demonstrou boa performance psicométrica do instrumento, confirmando sua adequação para uso no contexto 
cultural brasileiro. 
Descritores: Qualidade de vida; Asma; Estudos de validação.
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was that published in 2002 by the National 
Asthma Council Australia, which includes the 
following categories of asthma: infrequent 
episodic asthma, frequent episodic asthma, and 
chronic asthma.(8) For the purpose of our study, 
we included only individuals classified as having 
frequent episodic asthma, who, accordingly, 
used inhaled corticosteroids on a regular basis. 
Those experiencing an exacerbation at the time 
of enrollment were not selected for inclusion.
We collected data related to the following 
variables: socioeconomic status; Fischer asthma 
control scale score(9); FEV1, expressed as the 
percentage of predicted, according to the 
reference values established by Knudson et al.
(10); and family functioning, as per the Family 
Adaptability and Cohesion Evaluation Scale III 
(FACES III).(11)
In order to assess socioeconomic status, 
we used the Brazilian criteria, based on the 
1997 Brazilian Association of Survey Firms 
scale.(12) Using the scores obtained by combining 
educational and economic information, this 
scale identifies five socioeconomic categories, 
ordered from highest to lowest. The Fischer 
asthma control scale assesses disease control 
between follow-up visits.(9) We used a modified 
version of that scale, applied during the retest 
visit. Scores range from 1 (in use of regular 
inhaled corticosteroids, with no exacerbations) 
to 4 (hospitalization due to exacerbation). 
Spirometric tests were conducted using a 
SpiroDoc® spirometer (Medical International 
Research, Rome, Italy), in accordance with the 
American Thoracic Society/European Respiratory 
Society recommendations.(13) Pulmonary function 
was classified according to FEV1 (% of predicted) 
as follows: normal (80-100%); mild obstruction 
(60-79%); or moderate obstruction (41-59%). 
The FACES III scale is a twenty-item scale that 
evaluates family functioning by combining two 
domains, cohesion and adaptability, which allow 
families to be classified as being at low, medium 
or high risk for psychological disorders. We used 
the Brazilian Portuguese-language version of 
FACES III, which has been validated for use in 
Brazil.(14)
The psychometric properties we studied were 
validity and reliability. Validity was assessed 
on the basis of convergent validity, evaluating 
whether the domains measured in the PAQLQ 
correlated well with equivalent domains in a 
Introduction
The progressive use of health-related quality 
of life (HRQoL) measures, combined with more 
traditional clinical endpoints in medicine, has 
shown great potential for improving the health 
care of patients, particularly that of those with 
chronic conditions.(1,2) When such measures have 
been developed in a country other than that in 
which they will be applied, the appropriateness 
of the validation process (translation into the 
local language and adaptation for use in the 
target cultural context) is as important as is the 
selection of the instrument itself.(3)
There are approximately eleven specific 
questionnaires designed to assess HRQoL in 
children with asthma.(4,5) The most well-known 
and widely used of those is the Paediatric Asthma 
Quality of Life Questionnaire (PAQLQ).(6) In 2001, 
the PAQLQ was supposedly validated for use in 
Brazil under the guidance of the MAPI Research 
Institute, a center specializing in the validation 
of HRQoL instruments. However, no study 
reported the results of this validation process. 
When queried, the MAPI staff stated that they 
had accredited only the linguistic component, 
having tested it in a small sample, consisting of 
11 children (7-17 years of age).
Field testing is fundamental in the process of 
validating a questionnaire. It allows researchers 
to determine the psychometric properties and 
acceptability of the instrument, as well as 
its general applicability to cultural groups or 
subgroups.(7) In order to meet the need for a full 
validation of this important questionnaire in the 
Brazilian cultural context, the aim of this study 
was to assess the psychometric properties of the 
PAQLQ in a representative group of Brazilian 
children and adolescents with asthma.
Methods
Between January and September of 2007, we 
enrolled a convenience sample of 125 children 
and adolescents with asthma, ranging from 8 to 
17 years of age. Subjects were being monitored, 
via the Porto Alegre Asthma Program, at the 
pediatric pulmonology outpatient clinic of the 
Hospital da Criança Santo Antônio, in the city 
of Porto Alegre, Brazil. The participants had 
been diagnosed with asthma based on signs, 
symptoms, clinical course, and response to 
treatment. The classification of severity used 
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scale, ranging from 0 (never) to 4 (always), values 
that are later transformed into an inverse linear 
scale from 0-100, a higher value indicating a 
better state. We used the Brazilian Portuguese-
language version adapted and supplied by MAPI 
upon our request.
After the participants had completed the 
HRQoL questionnaires during the retest visit, 
we also applied a modified version of the Global 
Index of Change (GIC) questionnaire in order to 
assess overall change between the two interviews.
(6) The GIC questionnaire consisted of a single 
question regarding the state of the asthma in 
comparison with that at the time of the test 
visit, and there were seven possible answers on 
a Likert scale, ranging from 1 (“a lot better”) 
to 4 (“about the same”) to 7 (“a lot worse”). 
For the analysis, subjects were divided into two 
subgroups: “change”, those who indicated either 
improvement or worsening between interviews; 
and “no change”, those who did not perceive a 
change. This allowed us to test the sensitivity to 
change and reproducibility of the PAQLQ.
Data processing was carried out with the 
Statistical Package for the Social Sciences, version 
13 (SPSS Inc., Chicago, IL, USA). To find an MID 
of 0.5 points in the PAQLQ total scores between 
the two interviews, the estimated sample size 
generic instrument, the Pediatric Quality of Life 
Inventory (PedsQL) 4.0.(15) Both instruments 
were applied twice (test-retest) by means of 
standardized interviews, with 4-5 weeks between 
the two tests, in order to avoid recall bias.
The reliability of the PAQLQ was assessed by 
determining the following: internal consistency 
(specific correlations between items, total and 
by domain); sensitivity to change (whether the 
instrument is capable of identifying differences in 
HRQoL between interviews); and reproducibility 
(whether the instrument produces similar results 
at different time points, assuming that the 
conditions are the same).(16) We also estimated 
the proportion of participants with the lowest 
and highest scores (floor/ceiling effect), in 
order to assess the discriminatory power of the 
instrument.(7) This last parameter, which should 
be < 15%, contributes to assessing aspects of 
validity and reliability.
The PAQLQ is a specific instrument to assess 
HRQoL in individuals with asthma who are 
between 7 and 17 years of age.(6) It can be self-
administered or completed during an interview. 
For the purposes of the present study, we chose 
the latter option. Originally developed in Canadian 
English, the PAQLQ has been translated into over 
twenty languages and has been either partially 
or fully validated for use in the corresponding 
cultures.(17) It has 23 items distributed in three 
domains: activity limitations (5 items), symptoms 
(10 items) and emotional function (8 items). 
Three items in the activity limitations domain 
are individualized for each patient, who chooses 
from a list of common activities/sports. All 
PAQLQ items are similarly answered by means of 
a 7-point Likert scale, ranging from 1 (severely 
affected) to 7 (unaffected). Items are then 
added, and their average represents the scores 
(total and by domain). The minimal important 
difference (MID) established for this instrument 
is 0.5 points.(18)
The PedsQL 4.0 is a generic questionnaire that 
was originally developed in American English.(15) 
The version for the age group we studied has 
23 items, divided into four domains: physical 
functioning (8 items), emotional functioning 
(5 items), social functioning (5 items), and 
school functioning (5 items). A fifth domain, 
psychosocial functioning, encompasses the 
scores for last three of the four primary domains. 
Each item has five possible answers on a Likert 
Table 1 - Characteristics of the 125 patients included 
in the study.
Characteristic n %
Gender
Male 75 60.0
Female 50 40.0
Pulmonary function
Normal 102 81.8
Mild obstruction 23 19.1
Change between interviewsa 
Change 106 84.8
No change 19 15.0
Family psychological risk
Low 36 32.1
Medium 61 54.5
High 15 13.4
Socioeconomic status
Very low 8 7.2
Low 37 33.0
Medium 56 50.0
Medium high 11 9.8
High 0 0.0
aGlobal Index of Change.
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scores and the various demographic variables 
were also assessed.
Internal consistency was estimated by 
calculating the Cronbach’s alpha coefficient for 
the PAQLQ during the test. The sensitivity to 
change was estimated by calculating the effect 
size of the differences between the two interviews 
in the GIC “change” subgroup. Reproducibility 
was estimated by determining the intraclass 
correlation coefficient (ICC) between interviews 
was 36 subjects, with alpha and beta errors set 
at 5% and 20%, respectively.
For each questionnaire, the two interviews 
were compared by means of paired t-tests. 
We used Pearson’s correlation coefficient (r) 
to determine the strength of the association 
between the instruments (total scores and similar 
domains). Values of r > 0.3 were considered 
acceptable. Correlations between the PAQLQ 
Table 2 - Correlations of the Paediatric Asthma Quality of Life Questionnaire scores (Brazilian Portuguese-
language version) with the Pediatric Quality of Life Inventory 4.0 scores (Brazilian Portuguese-language version) 
and demographic variables in the 125 participants.
Variable PAQLQ scores, r (p)
Total Domain
Activity 
limitations
Emotional 
function
Symptoms
PedsQL 4.0 domains
Total 0.37 (< 0.001)
Physical functioning 0.34 (< 0.001)
Emotional functioning 0.40 (< 0.001)
Pulmonary function
FEV1 0.37 (< 0.001) 0.36 (< 0.001) 0.34 (0.001) 0.33 (0.001)
Age 0.47 (< 0.001) 0.40 (< 0.001) 0.45 (< 0.001) 0.42 (< 0.001)
Fischer asthma control scale −0.22 (0.080) −0.21 (0.097) −0.14 (0.245) −0.24 (0.051)
Global Index of Change 0.95 (0.323) 0.68 (0.481) 0.98 (0.308) 0.09 (0.346)
Adherence index 0.11 (0.240) 0.08 (0.401) 0.13 (0.179) 0.09 (0.329)
Socioeconomic status 0.18 (0.590) 0.24 (0.013) 0.18 (0.068) 0.08 (0.425)
Family cohesiona 0.11(0.270) 0.10 (0.277) 0.08 (0.361) −0.10 (0.308)
Family adaptabilitya −0.08 (0.425) −0.07 (0.459) −0.085(0.374) −0.06 (0.562)
PAQLQ: Paediatric Asthma Quality of Life Questionnaire; and PedsQL: Pediatric Quality of Life Inventory. aAccording to the 
Family Adaptability and Cohesion Evaluation Scale III.
Table 3 - Overall scores in the Paediatric Asthma Quality of Life Questionnaire (Brazilian Portuguese-language 
version): floor/ceiling effects and reliability results.
Variable PAQLQ scores
Total Domain
Activity  
limitations
Emotional 
function
Symptoms
Items, n 23 5 8 10
Theoretical score, range 1-7 1-7 1-7 1-7
Measured score, range 2.2-7 2.8-7 2.2-7 1.3-7
Mean ± SD 5.1 ± 1.1 4.9 ± 1.2 5.3 ± 1.3 5.2 ± 1.2
Floor effect, n (%) 0 (0) 0 (0) 0 (0) 0 (0)
Ceiling effect, n (%) 2 (1.6) 7 (5.6) 11 (8.8) 3 (2.4)
α-C, total 0.93 0.72 0.86 0.88
α-C, rangea 0.93-0.93 0.65-0.71 0.83-0.85 0.86-0.87
Reproducibilityb 0.80 0.66 0.79 0.74
Sensitivity to changec 0.60 0.60 0.56 0.45
PAQLQ: Paediatric Asthma Quality of Life Questionnaire; and α-C: Cronbach’s alpha coefficient. aRange of values by 
domain. bEffect size in the “Change” subgroup. cIntraclass correlation coefficient in the “No Change” subgroup.
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scores being lowest (4.99) for the activity 
limitations domain and highest (5.20) for the 
asthma symptoms domain. Although none of 
the participants made the lowest possible score 
for the emotional function domain, some (8.8%) 
attained the highest possible score for that 
domain. The Cronbach’s alpha coefficient was 
0.65 for the activity limitations domain, whereas 
it was ≥ 0.7 for all of the other domains, as well 
as for the homogeneity within each domain. For 
the two subgroups (“change” and “no change”), 
the changes over time were at acceptable levels 
(Table 4). In the “change” subgroup, the effect 
size was 0.6, and the ICC was 0.8 in the “no 
change” subgroup. The lowest values were for 
reproducibility in the activity limitations domain 
(0.66) and for sensitivity to change in the asthma 
symptoms domain (0.45). Differences between 
test and retest scores were greater than the MID 
in the “change” subgroup.
Discussion
The psychometric results of our field testing 
demonstrate the cultural adequacy of the official 
Brazilian Portuguese-language version of the 
PAQLQ, which can therefore now be considered 
validated for use in Brazil.
A different and independent Brazilian version 
of the PAQLQ was validated in 2005.(19) Although 
there were some methodological objections,(20) 
the authors certainly made a great investment 
of time and resources to develop a thorough 
validation process starting from zero. However, 
the resulting version is not available and would 
not be applicable, since the original author of 
the PAQLQ allows the use only of MAPI versions.
(17) This added to the prevailing confusion 
in the “no-change” subgroup. Cronbach’s alpha 
coefficient and the ICC values were considered 
adequate if ≥ 0.7. To calculate the effect size, we 
used the method that includes the test and retest 
standard deviations. Conventional interpretation 
of effect size values is as follows: 0.2 = small; 
0.5 = medium; and 0.8 = large.(16)
The study was approved by the review board 
of the institution, parents gave written informed 
consent, and the participants verbally agreed 
to be included in the study. Permission to use 
each of the questionnaires was granted by the 
corresponding copyright holders or their agents.
Results
A total of 125 children and adolescents 
participated in the study, and the mean age 
was 11 years. Males accounted for more than 
half of all subjects, and 82% of the participants 
had normal lung function. Most of the families 
(67.9%) were at medium or high risk for 
psychological disorders, and the socioeconomic 
status was low or very low in 40% of cases. 
Table 1 summarizes the characteristics of our 
study sample.
Table 2 shows how the PAQLQ scores 
correlated with the PedsQL scores and with the 
various demographic variables. The instruments 
correlated reasonably well with each other in 
terms of the total scores and the scores for 
equivalent domains, suggesting an acceptable 
convergent validity.(16). Variables related to 
socioeconomic status or family risk correlated 
weakly with the PAQLQ scores.
The overall reliability and floor/ceiling effects 
of the PAQLQ are shown in Table 3. The mean 
PAQLQ total score was 5.18, the mean domain 
Table 4 - The Paediatric Asthma Quality of Life Questionnaire scores: test-retest reproducibility and sensitivity 
to change.
PAQLQ score Subgroup Mean scores Difference p ES ICC
Test Retest
Total Change 5.10 5.78 0.68* < 0.001 0.60 N/A
No change 5.54 5.94 0.39 0.032 N/A 0.80
Activity limitations Change 4.89 5.65 0.75* < 0.001 0.60 N/A
No change 5.41 5.94 0.53* 0.020 N/A 0.66
Emotional function Change 5.27 6.01 0.74* < 0.001 0.56 N/A
No change 5.64 6.08 0.43 0.061 N/A 0.79
Symptoms Change 5.13 5.67 0.54* < 0.001 0.45 N/A
No change 5.59 5.82 0.23 0.298 N/A 0.74
PAQLQ: Paediatric Asthma Quality of Life Questionnaire; ES: effect size; and ICC: intraclass correlation coefficient. 
*≥ minimal important difference.
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of 0.3-0.4 between total scores on HRQoL 
instruments and FEV1 are now considered 
adequate.(2) However, unlike what would be 
expected,(28) socioeconomic status correlated 
weakly with the PAQLQ scores. Although 
40% of participants were in the two lowest 
socioeconomic strata, the mean score for our 
sample as a whole was 5.1, out of a maximum 
possible score of 7, which suggests the group 
had an acceptable HRQoL. Proper functioning of 
health care microsystems could account for these 
particular results since they can have a positive 
impact on patient quality of life, as suggested 
in different studies, including that carried out in 
the city of Porto Alegre, Brazil.(29)
Our study has some limitations. We had a 
smaller number of subjects in the subgroup 
of patients who reported no changes in their 
asthma-related health status. That might have 
limited our assessment of reproducibility. 
However, the reproducibility of their PAQLQ 
results was in accordance with their reportedly 
unchanged state. Our sample size, however, was 
larger than the estimated sample size needed 
in order to perform our core analysis, as well 
as being larger than those evaluated in other 
PAQLQ validation studies. The decision not to 
include cases of asthma that were more severe 
could be considered another limitation. Severe 
asthma is certainly a great challenge for clinicians 
and asthma control programs, but we preferred 
to include only the most important category 
in terms of epidemiology, frequent episodic 
asthma, which is equivalent to the sum of the 
mild persistent asthma and moderate persistent 
asthma categories outlined in the Brazilian 
Guidelines for Asthma Management.(30)
In conclusion, based on our field testing, the 
Brazilian Portuguese-language version of the 
PAQLQ, developed by the MAPI in 2001, shows 
good convergent validity, internal consistency, 
sensitivity to change, reproducibility, and 
discriminatory power. Consequently, we can 
state that the psychometric performance of this 
version of the PAQLQ is acceptable.
Acknowledgments
We thank Prof. José Moreira and Mr. Marco 
A. da Silva (Pulmonology Post-Graduate Program 
of the Federal University of Rio Grande do Sul) 
for their support throughout the study.
regarding the availability of a Brazilian version 
of the questionnaire, since the only published 
validation study of the instrument did not 
employ the official version, and the resulting 
questionnaire was not made available, because 
it was unauthorized. In addition, field testing of 
the official version has not been performed since 
2001, and its psychometric adequacy therefore 
cannot be confirmed. We hope that our findings 
will overcome these misunderstandings.
There are similarities between our 
psychometric findings and those of the original 
English-language version, as well as between our 
results and those obtained in versions in other 
languages. A PubMed database search (March 
of 2009) for PAQLQ validation studies rendered 
13 articles, 8 of which were cultural validation 
studies.(19,21-27) Of those, there were two different 
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author of the PAQLQ did in the original study, not 
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